Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 12/23/2022
Closing price: 111.86
Support price level: | $100.61 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 57.2 |
Beta | 0.37 |
- MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 47.7 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- MRK is one of this month's top performers with a return of 4.1 percent, beating 90 percent of stocks in the S&P-100.
- The price of this low-beta stock is expected to increase by 0.37% for every 1% increase in the S&P-500.
- MRK is one of this week's least volatile stocks in the S&P-100 with an estimated annualized standard deviation of 17.5%.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$73.51 | $111.86 | 100.0% |
200 day | 50 day | 20 day | 10 day |
$92.01 | $103.82 | $109.98 | $110.36 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
22.4% | 21.5% | 17.5% | 20.3% |
- 4.8% in the next week.
- 11.5% in the next month.
- 43.3% in the next year.
Company news for Merck & Co
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks